<--- Back to Details
First PageDocument Content
Pharmacology / Health / Clinical pharmacology / Therapeutics / United States Public Health Service / Regulatory science / Regulatory requirement / Reagan-Udall Foundation / Critical Path Institute / Pharmaceutical sciences / Clinical research / Food and Drug Administration
Pharmacology
Health
Clinical pharmacology
Therapeutics
United States Public Health Service
Regulatory science
Regulatory requirement
Reagan-Udall Foundation
Critical Path Institute
Pharmaceutical sciences
Clinical research
Food and Drug Administration

Advancing Regulatory Science FY 2011

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 118,61 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document